May 27 (Reuters) - Nikkei :
* Is gearing up to sell generic drugs in the U.S. - Nikkei
* Expects to win FDA approval to sell generic version of cholesterol drug
Pitavastatin starting between April and September 2017 - Nikkei
* Also plans to have three other generics in the pipeline for FDA approval in
the fiscal year ending in March 2018 - Nikkei
* Pharmaceutical's move into U.S. and higher capacity likely will spur co to
raise its group sales target for year ending in March 2018 - Nikkei
* Source text (http://s.nikkei.com/1Z3MoAC)
* ((For more news, please click here 4555.T )) ((Bengaluru Newsroom; +91 806749 1130))